Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | $92.0M | $232.2M | $189.2M | $265.7M | $208.5M | $296.5M | $161.0M | $131.6M | $237.2M | $144.3M | $81.4M | $23.6M | $25.6M | ($38.9M) | ($141.3M) | ($100.2M) | ($279.7M) | ($428.0M) | ($560.4M) | ($544.9M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, West Pharmaceutical Services, Inc.'s last 12-month Net Debt is ($186.1M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, West Pharmaceutical Services, Inc.'s Net Debt growth was (67.7%). The average annual Net Debt growth rates for West Pharmaceutical Services, Inc. have been 6.8% over the past three years, 9.6% over the past five years.
Over the last year, West Pharmaceutical Services, Inc.'s Net Debt growth was (67.7%), which is lower than industry growth of (0.8%). It indicates that West Pharmaceutical Services, Inc.'s Net Debt growth is Good.